glp-1 agonist therapy consultation preparation Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1 Essentials - TRC Healthcare

The incidence of acute pancreatitis, as confirmed by post-marketing monitoring data, are less than 0.1%, which is in line with the rates seen in the general diabetic population

Think of Zepbound as using two complementary approaches simultaneously rather than relying on one very effective approach

New Frontiers in the Intrarenal Renin-Angiotensin System: A Critical Review of Classical and New Paradigms

NAION and GLP-1 RAs Recent studies have indicated a possible link between GLP-1 receptor agonists semaglutide and liraglutide and an increased risk of NAION, or non-arteritic anterior ischemic optic neuropathy

doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach